Literature DB >> 19513799

Early equivalence of uncemented press-fit and Compress femoral fixation.

German L Farfalli1, Patrick J Boland, Carol D Morris, Edward A Athanasian, John H Healey.   

Abstract

UNLABELLED: Bone ingrowth promises more durable biologic fixation of megaprostheses. The relative performance of different types of fixation is unknown. We compared the fixation of two forms of biologically fixed femoral components: an intramedullary uncemented press-fit stem (UCS; Group 1, 50 patients) and a Compress((R)) uncemented fixation (CPS; Group 2, 41 patients). In Group 1, the overall Kaplan-Meier prosthetic survival rates were 85% at 5 and 71% at 10 years. Most failures were long-term developments. Aseptic loosening was the primary cause of failure. Stem diameters less than 13.5 mm and a diaphyseal/stem coefficient greater than 2.5 mm were associated with decreased prosthetic survival. In Group 2, the overall rate of CPS survival was 88% at 5 years. Failure of femoral fixation or fracture during the first year was the main reason for revision. Five-year survival rates were similar between the groups and we observed no difference in the functional success of the implants. We found no failures after 1-year followup in Group 2 (CPS). Any difference in prosthetic survival can only be proven by longer-term study or a randomized trial. LEVEL OF EVIDENCE: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19513799      PMCID: PMC2758982          DOI: 10.1007/s11999-009-0912-9

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  34 in total

1.  Prosthetic knee replacement after resection of a malignant tumor of the distal part of the femur. Medium to long-term results.

Authors:  A Kawai; G F Muschler; J M Lane; J C Otis; J H Healey
Journal:  J Bone Joint Surg Am       Date:  1998-05       Impact factor: 5.284

2.  In vitro testing of a novel limb salvage prosthesis for the distal femur.

Authors:  Luca Cristofolini; Stefano Bini; Aldo Toni
Journal:  Clin Biomech (Bristol, Avon)       Date:  1998-12       Impact factor: 2.063

3.  Revision of the Kotz type of tumour endoprosthesis for the lower limb.

Authors:  F Mittermayer; R Windhager; M Dominkus; P Krepler; E Schwameis; M Sluga; R Kotz; G Strasser
Journal:  J Bone Joint Surg Br       Date:  2002-04

4.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark Krailo; Eugenie S Kleinerman; Donna Betcher; Mark L Bernstein; Ernest Conrad; William Ferguson; Mark Gebhardt; Allen M Goorin; Michael B Harris; John Healey; Andrew Huvos; Michael Link; Joseph Montebello; Helen Nadel; Michael Nieder; Judith Sato; Gene Siegal; Michael Weiner; Robert Wells; Lester Wold; Richard Womer; Holcombe Grier
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

5.  Relationship between magnitude of resection, complication, and prosthetic survival after prosthetic knee reconstructions for distal femoral tumors.

Authors:  A Kawai; P P Lin; P J Boland; E A Athanasian; J H Healey
Journal:  J Surg Oncol       Date:  1999-02       Impact factor: 3.454

6.  Limb salvage surgery in bone tumour with modular endoprosthesis.

Authors:  B K Sanjay; P G Moreau
Journal:  Int Orthop       Date:  1999       Impact factor: 3.075

7.  Aseptic loosening is uncommon with uncemented proximal tibia tumor prostheses.

Authors:  Michael N Flint; Anthony M Griffin; Robert S Bell; Peter C Ferguson; Jay S Wunder
Journal:  Clin Orthop Relat Res       Date:  2006-09       Impact factor: 4.176

8.  Prosthetic and extremity survivorship after limb salvage for sarcoma. How long do the reconstructions last?

Authors:  S M Horowitz; D B Glasser; J M Lane; J H Healey
Journal:  Clin Orthop Relat Res       Date:  1993-08       Impact factor: 4.176

9.  Distal femur resection with endoprosthetic reconstruction: a long-term followup study.

Authors:  Jacob Bickels; James C Wittig; Yehuda Kollender; Robert M Henshaw; Kristen L Kellar-Graney; Issac Meller; Martin M Malawer
Journal:  Clin Orthop Relat Res       Date:  2002-07       Impact factor: 4.176

10.  Effect of chemotherapy on initial compressive osseointegration of tumor endoprostheses.

Authors:  R S Avedian; R E Goldsby; M J Kramer; R J O'Donnell
Journal:  Clin Orthop Relat Res       Date:  2007-06       Impact factor: 4.176

View more
  30 in total

1.  Surgical technique: Methods for removing a Compress® compliant prestress implant.

Authors:  Geoffrey D Abrams; Varun K Gajendran; David G Mohler; Raffi S Avedian
Journal:  Clin Orthop Relat Res       Date:  2011-10-15       Impact factor: 4.176

2.  Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.

Authors:  Krista A Goulding; Adam Schwartz; Steven J Hattrup; R Lor Randall; Donald Lee; Damian M Rispoli; Daniel M Lerman; Christopher Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2017-02-13       Impact factor: 4.176

3.  How Often Does Spindle Failure Occur in Compressive Osseointegration Endoprostheses for Oncologic Reconstruction?

Authors:  Lauren H Goldman; Lee J Morse; Richard J O'Donnell; Rosanna L Wustrack
Journal:  Clin Orthop Relat Res       Date:  2016-04-22       Impact factor: 4.176

4.  Radiographic assessment of distal femur cemented stems in tumor endoprostheses.

Authors:  R E Turcotte; N A Stavropoulos; J Toreson; M Alsultan
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-04-28

5.  Hydroxyapatite-coated collars reduce radiolucent line progression in cemented distal femoral bone tumor implants.

Authors:  Melanie J Coathup; Anish Sanghrajka; William J Aston; Panagiotis D Gikas; Robin C Pollock; Stephen R Cannon; John A Skinner; Timothy W R Briggs; Gordon W Blunn
Journal:  Clin Orthop Relat Res       Date:  2015-01-30       Impact factor: 4.176

6.  What Factors Are Associated With Failure of Compressive Osseointegration Fixation?

Authors:  Ryland Kagan; Jacob Adams; Caroline Schulman; Rachel Laursen; Karina Espana; Jung Yoo; Yee-Cheen Doung; James Hayden
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

Review 7.  Compressive osseointegration into a custom acetabular implant masquerading as tumor recurrence: a case report.

Authors:  Adam J Schwartz; Christopher P Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

8.  Antirotation pins improve stability of the compress limb salvage implant: a biomechanical study.

Authors:  Raffi S Avedian; Timothy Chen; Derek Lindsey; Ariel Palanca; David Mohler
Journal:  Clin Orthop Relat Res       Date:  2014-09-11       Impact factor: 4.176

9.  Chemotherapy Curtails Bone Formation From Compliant Compression Fixation of Distal Femoral Endoprostheses.

Authors:  Mohammad A Elalfy; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

10.  Revision Distal Femoral Arthroplasty With the Compress(®) Prosthesis Has a Low Rate of Mechanical Failure at 10 Years.

Authors:  Melissa N Zimel; German L Farfalli; Alexandra M Zindman; Elyn R Riedel; Carol D Morris; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2015-09-22       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.